Strategic Advocates’s iShares Core MSCI Emerging Markets ETF IEMG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$907K Sell
12,999
-305,232
-96% -$22M 4.01% 6
2025
Q4
$21.4M Buy
318,231
+10,330
+3% +$693K 5.49% 5
2025
Q3
$20.3M Buy
307,901
+8,871
+3% +$553K 5.29% 5
2025
Q2
$18M Buy
299,030
+2,307
+0.8% +$129K 5.33% 6
2025
Q1
$16M Buy
296,723
+17,595
+6% +$947K 5.57% 6
2024
Q4
$14.6M Buy
279,128
+38,870
+16% +$2.15M 4.92% 7
2024
Q3
$13.8M Buy
240,258
+350
+0.1% +$18.9K 4.94% 6
2024
Q2
$12.8M Buy
239,908
+9,084
+4% +$479K 5.09% 6
2024
Q1
$11.9M Buy
230,824
+115,516
+100% +$5.78M 4.59% 6
2023
Q4
$5.83M Buy
115,308
+59,261
+106% +$2.87M 2.48% 11
2023
Q3
$2.67M Buy
+56,047
New +$2.77M 1.26% 17

Other funds holding IEMG

Strategic Advocates's IEMG Position: Q1 2026 in Review

Strategic Advocates reduced its iShares Core MSCI Emerging Markets ETF (IEMG) stake by 96% in Q1 2026, selling an estimated $22M and leaving 12,999 shares worth $907K. The position accounts for 4.01% of the portfolio, ranked #6.

Strategic Advocates first reported a position in IEMG in Q3 2023 and has held it in 11 quarters since. The position peaked at $21.4M in Q4 2025. 2,285 funds tracked by Wall St. Rank hold IEMG as of Q1 2026.

  • Strategic Advocates held 12,999 shares of iShares Core MSCI Emerging Markets ETF worth $907K as of Q1 2026.
  • Strategic Advocates sold 305,232 iShares Core MSCI Emerging Markets ETF shares in Q1 2026, an estimated $22M.
  • iShares Core MSCI Emerging Markets ETF made up 4.01% of Strategic Advocates's portfolio in Q1 2026, its #6 holding.
  • Strategic Advocates first reported a position in iShares Core MSCI Emerging Markets ETF in Q3 2023 and has held it in 11 quarters since.
  • Strategic Advocates's iShares Core MSCI Emerging Markets ETF position peaked at $21.4M in Q4 2025.
  • 2,285 funds tracked by Wall St. Rank held iShares Core MSCI Emerging Markets ETF as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.